Board of Directors
Ying Luo, PhD
Director, Representative Executive Officer, President and CEO
Dr. Luo completed his undergraduate education at Peking Union Medical College (Peking University's Premedicine) in 1982 and received his doctorate in biomedical sciences from the University of Connecticut Health Center in 1991. During 1993, he joined the University of California, San Francisco as a postdoctoral fellow studying HIV gene regulation. Prior to Shanghai Genomics Dr. Luo gained experience at various biotech firms, including Aviron, Clonetech, and served as the senior director of Genomics and Target Discovery at Rigel Pharmaceuticals. He is currently President and CEO of GNI Group and General Manager of Shanghai Genomics. Dr Luo's research was in the field of protein-protein interactions in cancer and inflammation signaling pathways. In the last twenty years, Dr. Luo has authored more than 35 research publications in top scientific journals. His concurrent posts include Chairman of the Board of Shanghai Genomics, Inc., Beijing Continent Pharmaceutical Co., Ltd., GNI Hong Kong Limited, and Cullgen (Shanghai), Inc., Director of GNI USA, Inc. and Berkeley Advanced Biomaterials LLC, Chairman and Director of Cullgen Inc. etc.
Joseph Francis Meyer
Director, Executive Officer, CFO
Joe Meyer has 40 years of experience in financial services in the areas of investment banking, asset management and stock exchanges for each of which he has held executive committee or other senior operating management positions. Following a one-year "sabbatical" focused on renewable energy in Hong Kong, and before joining GNI, Mr. Meyer was COO, CFO and board member of Chi-X Asia Pacific Group (now CBOE Asia Pacific) working for the J.C. Flowers private equity firm. His work experiences have included the Global Investments Division at Aflac in NY and Tokyo, the Hong Kong Stock Exchange, Shinsei Bank in Japan, Deutsche Asset Management in NY, Deutsche Securities in Tokyo. He began His career began in 1982 with Morgan Guaranty Trust in NY, then on to Morgan Stanley in 1987 for which he relocated to Tokyo in 1992, then to Hong Kong in 1995. He returned to Japan in 2000 when he joined Deutsche Bank Group. Mr. Meyer received his bachelor of arts degrees with Honors in Government and East Asian Studies from Colby College in 1979 where he serves as a member of the Board of Visitors, and he was awarded a Thomas J. Watson Fellowship upon graduation. He has also served on the Board of Trustees of the American School in Japan.
Thomas Eastling has over 30 years' experience in global finance, M&A and business development, with a substantial part of his career in Asia. He started on Wall Street at Nikko Securities Co. International, Inc., rising to the position of Senior Vice President & General Manager of the Investment Banking and Syndicate Divisions. In the late 1990's, he moved to Japan as Company Representative for Duff & Phelps Credit Rating Co. and subsequently worked as Managing Director for Softbank Corp. in strategic planning and investor relations. In 2009 he relocated to Hong Kong with American Appraisal where he served as Director of the firm's Transaction Advisory Services in Asia. In September of 2013, Mr. Eastling returned to Japan in his current role as Executive Officer of GNI Group Ltd. Mr. Eastling has a Bachelor's degree from the University of Southern California and a Masters from the American Graduate School of International Management. He speaks Japanese and is pursuing Mandarin. He currently serves as Non-Executive Director for a Hong Kong private equity fund.
After graduating from Waseda University with a degree in Commerce, Hideaki Sashiwa has worked with major securities companies including Daiwa Securities Co.Ltd, Kleinwort Benson and Goldman Sachs where he cultivated his specialized knowledge about finance and investment. He is currently the President of Nippon Concierge Co., Ltd. and Representative Director and Vice-President of GI Capital Securities Ltd.
Kan-ichiro (Ken) Suzuki, Ph.D.
After more than 20 years of experience in investment research and management consulting at Nomura Research Institute (NRI), Professor Suzuki played a major role in the development of the GNI Group as a founding member of Gene Networks, Inc (GNI), the predecessor of GNI. Since 2009, as a professor at Ritsumeikan Asia Pacific University, he has been conducting research on leadership, organizational functions, international management, ESG management, etc., and has published numerous academic papers and books. He is an emeritus professor at the university. He graduated from Waseda University Faculty of Political Science and Economics and received a Master of Business Administration (MBA) from UNC Kenan-Flagler Business School in the United States and a Ph.D. from Waseda University Graduate School of Asia Pacific Studies. He was also a visiting scholar at the Hoover Institution at Stanford University in the United States.
Yan Hao is the founder of EPS Holdings, Inc. He was born in November 1962 in Jiangsu Province, China. He entered the Department of Electronic Engineering at Tianjin University in 1979 and came to Japan in 1981 as a Government Scholarship student. After graduating from the University of Yamanashi, he studied medical statistics in the doctoral program at the University of Tokyo, while he was also involved in research and practice of clinical trials. In May 1991, he founded EPS Tokyo Inc. (currently EPS Holdings Inc.), which became the first CRO company listed in JASDAQ in July 2001 and the first section of the Tokyo Stock Exchange in September 2006. Currently, he is the Representative Director of EPS Holdings Inc., Representative Director of Chinese Chamber of Commerce in Japan, Vice President of Japan-China Medical Communication Center, a visiting professor at the University of Yamanashi, and a Director of Learning Health Society Institute.